Latent infection of myeloid progenitors by human cytomegalovirus protects cells from FAS-mediated apoptosis through the cellular IL-10/PEA-15 pathway.
dc.contributor.author | Poole, Emma | |
dc.contributor.author | Lau, Jonathan CH | |
dc.contributor.author | Sinclair, John | |
dc.date.accessioned | 2015-06-08T11:21:03Z | |
dc.date.available | 2015-06-08T11:21:03Z | |
dc.date.issued | 2015-08 | |
dc.identifier.citation | Journal of General Virology, August 2015 96: 2355-2359, doi: 10.1099/vir.0.000180 | |
dc.identifier.issn | 0022-1317 | |
dc.identifier.uri | https://www.repository.cam.ac.uk/handle/1810/248311 | |
dc.description.abstract | Latent infection of primary CD34(+) progenitor cells by human cytomegalovirus (HCMV) results in their increased survival in the face of pro-apoptotic signals. For instance, we have shown previously that primary myeloid cells are refractory to FAS-mediated killing and that cellular IL-10 (cIL-10) is an important survival factor for this effect. However, how cIL-10 mediates this protection is unclear. Here, we have shown that cIL-10 signalling leading to upregulation of the cellular factor PEA-15 mediates latency-associated protection of CD34(+) progenitor cells from the extrinsic death pathway. | |
dc.description.sponsorship | We gratefully acknowledge funding from the UK Medical Research Council (J.H.S. G:0701279) which supports the current research in our laboratory and also the support of NIHR UK Biomedical Research Centre (J.H.S.). We thank Linda Teague, Roy Whiston and Stuart McGregor Dallas for technical support and Stuart McGregor Dallas for providing validation data for figure 1. | |
dc.language | English | |
dc.language.iso | en | |
dc.publisher | Microbiology Society | |
dc.rights | Attribution 2.0 UK: England & Wales | |
dc.rights | Creative Commons Attribution License 2.0 UK | |
dc.rights.uri | http://creativecommons.org/licenses/by/2.0/uk/ | |
dc.title | Latent infection of myeloid progenitors by human cytomegalovirus protects cells from FAS-mediated apoptosis through the cellular IL-10/PEA-15 pathway. | |
dc.type | Article | |
dc.description.version | This is the final version. It first appeared at http://jgv.sgmjournals.org/content/journal/jgv/10.1099/vir.0.000180. | |
prism.endingPage | 2359 | |
prism.publicationDate | 2015 | |
prism.publicationName | J Gen Virol | |
prism.startingPage | 2355 | |
prism.volume | 96 | |
dc.rioxxterms.funder | MRC | |
dc.rioxxterms.funder | NIHR | |
dc.rioxxterms.projectid | G:0701279 | |
rioxxterms.versionofrecord | 10.1099/vir.0.000180 | |
rioxxterms.licenseref.uri | http://www.rioxx.net/licenses/all-rights-reserved | |
rioxxterms.licenseref.startdate | 2015-05-08 | |
dc.contributor.orcid | Poole, Emma [0000-0003-3904-6121] | |
dc.contributor.orcid | Sinclair, John [0000-0002-2616-9571] | |
dc.identifier.eissn | 1465-2099 | |
rioxxterms.type | Journal Article/Review | |
pubs.funder-project-id | Medical Research Council (MR/K021087/1) | |
pubs.funder-project-id | Medical Research Council (G0701279) | |
cam.issuedOnline | 2015-05-08 | |
rioxxterms.freetoread.startdate | 2050-01-01 |
Files in this item
This item appears in the following Collection(s)
-
Scholarly Works - Medicine
-
Symplectic mapped items for data match
This collection contains all articles, datasets and conference objects to be harvested